<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=187063"><dc:title>Involvement of Long Non-Coding RNAs in Triple-Negative Breast Cancer</dc:title><dc:creator>Stanojević,	Andrea	(Avtor)
	</dc:creator><dc:creator>Kunej,	Tanja	(Mentor)
	</dc:creator><dc:creator>Pajič,	Tadej	(Komentor)
	</dc:creator><dc:subject>TNBC</dc:subject><dc:subject>lncRNA</dc:subject><dc:subject>TME</dc:subject><dc:subject>immune escape</dc:subject><dc:subject>metastasis</dc:subject><dc:subject>biomarkers</dc:subject><dc:subject>therapeutic targets</dc:subject><dc:description>This thesis examines the role of long non-coding RNAs (lncRNAs) in the progression of
triple-negative breast cancer (TNBC), with particular focus on immune escape, cell
survival, and invasion and metastasis. The work is based on a review and integration of
current literature, with emphasis on lncRNAs for which experimentally supported
molecular mechanisms have been described. The findings show that lncRNAs can act at
several levels of tumor regulation and may have either oncogenic or tumor-suppressive
functions. In immune regulation, lncRNAs such as LINK-A and GATA3-AS1 promote
immune escape, while LINC01198 supports anti-tumor immune recognition. In the
regulation of cell survival, H19 and NEAT1 promote proliferation and resistance to
apoptosis, whereas GAS5 and PTCSC3 support tumor-suppressive processes. During
invasion and metastasis, MALAT1 and PCAT6 promote metastatic behavior, while
LINC00921 suppresses epithelial-to-mesenchymal transition and invasion. The reviewed
evidence also indicates potential clinical value of lncRNAs as prognostic and predictive
biomarkers and as therapeutic targets. However, most available evidence remains
preclinical, and the heterogeneity of TNBC and context-dependent functions of lncRNAs
currently limit their clinical application. Further validation in larger patient cohorts and
more representative experimental models is therefore required.</dc:description><dc:date>2026</dc:date><dc:date>2026-09-09 07:16:33</dc:date><dc:type>Diplomsko delo/naloga</dc:type><dc:identifier>187063</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
